Inomata Takenori, Hua Jing, Nakao Takeshi, Shiang Tina, Chiang Homer, Amouzegar Afsaneh, Dana Reza
Department of Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA.
Cornea. 2018 Jan;37(1):95-101. doi: 10.1097/ICO.0000000000001400.
To assess the effect of dry eye disease (DED) in graft donors on dendritic cell (DC) maturation, host T-cell sensitization, and corneal allograft rejection.
Corneas of control (healthy donor) and DED mice (C57BL/6) were transplanted onto fully allogeneic naive BALB/c recipients (n = 10 mice/group). Long-term allograft survival was evaluated for 8 weeks. Corneas and draining lymph nodes (dLNs) were harvested at posttransplantation day 14 (n = 5 mice/group). The frequencies of MHCII CD11c DCs in the donor corneas and host dLNs and the frequencies of interferon (IFN)-γ and IL-17 CD4 T cells and Foxp3 expression by Tregs in host dLNs were investigated using flow cytometry. The enzyme-linked immunospot assay was used to assess host T-cell allosensitization through direct and indirect pathways (n = 3/group).
Recipients of DED donor corneas showed significantly reduced graft survival (10%) compared with control mice (50% survival, P = 0.022), and had significantly increased frequencies of mature DCs in the grafted cornea (DED donor 44.0% ± 0.36% vs. healthy donor 35.4 ± 0.5%; P < 0.0001) and host dLNs (DED donor 25.1% ± 0.66% vs. healthy donor 13.7% ± 1.6%; P = 0.005). Frequencies of IFN-γ and IL-17 T cells were increased in the dLNs of recipients of DED corneas, whereas the expression (mean fluorescence intensity) of Foxp3 in Tregs was decreased significantly in these mice (DED donor 6004 ± 193 vs. healthy donor 6806 ± 81; P = 0.0002). Enzyme-linked immunospot analysis showed that the direct pathway of allosensitization was significantly amplified in recipients of grafts with DED (P = 0.0146).
Our results indicate that DED in the donor is a significant risk factor for subsequent corneal allograft rejection.
评估供体干眼疾病(DED)对树突状细胞(DC)成熟、宿主T细胞致敏及角膜移植排斥反应的影响。
将对照(健康供体)和DED小鼠(C57BL/6)的角膜移植到完全同种异体的未致敏BALB/c受体小鼠上(每组n = 10只小鼠)。评估角膜移植长期存活情况,为期8周。在移植后第14天采集角膜和引流淋巴结(dLN)(每组n = 5只小鼠)。采用流式细胞术检测供体角膜和宿主dLN中MHCII⁺CD11c⁺ DC的频率,以及宿主dLN中干扰素(IFN)-γ和IL-17⁺ CD4⁺ T细胞的频率和调节性T细胞(Tregs)中Foxp3的表达。采用酶联免疫斑点试验通过直接和间接途径评估宿主T细胞同种异体致敏情况(每组n = 3只)。
与对照小鼠相比,接受DED供体角膜移植的受体小鼠移植存活率显著降低(10%)(对照小鼠存活率为50%,P = 0.022),移植角膜中成熟DC的频率显著增加(DED供体为44.0% ± 0.36%,健康供体为35.4 ± 0.5%;P < 0.0001),宿主dLN中成熟DC的频率也显著增加(DED供体为25.1% ± 0.66%,健康供体为13.7% ± 1.6%;P = 0.005)。DED角膜受体小鼠的dLN中IFN-γ和IL-17⁺ T细胞的频率增加,而这些小鼠中Tregs中Foxp3的表达(平均荧光强度)显著降低(DED供体为6004 ± 193,健康供体为6806 ± 81;P = 0.0002)。酶联免疫斑点分析表明,DED供体角膜移植受体小鼠的同种异体致敏直接途径显著增强(P = 0.0146)。
我们的结果表明,供体的DED是随后角膜移植排斥反应的一个重要危险因素。